Welcome to Zila, Inc.

Zila, Inc. (Nasdaq: ZILA) headquartered in Phoenix, is a specialty pharmaceutical company focused on the prevention and treatment of oral cancer. 

• Zila, Inc., is a fully integrated oral diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease. ViziLite^® Plus with TBlue^®, the company's flagship product for the early detection of oral abnormalities that could lead to cancer, is the first and only adjunctive medical device cleared by the FDA for use in a population at increased risk for oral cancer. In addition, Zila designs, manufactures and markets a suite of proprietary products sold exclusively and directly to dental professionals for periodontal disease, including the Rotadent^® Professional Powered Brush, the Pro-Select Platinum^® ultrasonic scaler and a portfolio of oral pharmaceutical products for both in-office and home-care use.

   

Zila and TOLMAR are now one company! Get the exciting details here.